Physician profile
David Carter
NPI 1578943833
$3,287.24
in general payments reported to CMS, 2019-2025
9 companies · $1,947 in 2025
The $1,947 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2023: $96.35 · 2024: $989 · 2025: $1,947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,067 · Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,067.13 |
| Food and Beverage | $965.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,858.57 | 2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $989.37 | 2024 | |
| Acell, INC. | $121.31 | 2019 | |
| Zimmer Biomet Holdings, INC. | $119.54 | 2019 | |
| Integra Lifesciences Corporation | $62.77 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Rti Surgical, INC | $54.18 | 2023 | |
| Tela Bio, INC. | $42.17 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Aroa Biosurgery Incorporated | $25.61 | 2025 | |
| Sanofi-Aventis U.S. LLC | $13.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.